Among these biomarkers, FAP, a type II transmembrane glycoprotein, whose expression was selectively observed in CAFs and pericytes in most human epithelial cancers, was thought to facilitate tumor growth and proliferation [58, 59]. This evidence concerns the gene FAP and neoplasm.